JP Morgan Private Wealth Advisors’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-11,774
| Closed | -$365K | – | 1936 |
|
|
2022
Q2 | $365K | Sell |
11,774
-874
| -7% | -$29.8K | ﹤0.01% | 1567 |
|
|
2022
Q1 | $519K | Sell |
12,648
-2,321
| -16% | -$102K | ﹤0.01% | 1519 |
|
|
2021
Q4 | $651K | Sell |
14,969
-43,335
| -74% | -$1.96M | ﹤0.01% | 1443 |
|
|
2021
Q3 | $2.92M | Sell |
58,304
-866
| -1% | -$52.4K | 0.01% | 750 |
|
|
2021
Q2 | $3.73M | Sell |
59,170
-956
| -2% | -$61.4K | 0.01% | 664 |
|
|
2021
Q1 | $5.59M | Buy |
60,126
+2,525
| +4% | +$259K | 0.02% | 484 |
|
|
2020
Q4 | $5.16M | Buy |
57,601
+4,636
| +9% | +$425K | 0.02% | 469 |
|
|
2020
Q3 | $5.47M | Buy |
52,965
+778
| +1% | +$83.9K | 0.02% | 410 |
|
|
2020
Q2 | $4.13M | Buy |
52,187
+10,951
| +27% | +$816K | 0.02% | 401 |
|
|
2020
Q1 | $2.39M | Buy |
41,236
+27,505
| +200% | +$1.59M | 0.01% | 502 |
|
|
2019
Q4 | $741K | Sell |
13,731
-2,283
| -14% | -$124K | ﹤0.01% | 902 |
|
|
2019
Q3 | $837K | Buy |
16,014
+5,249
| +49% | +$245K | ﹤0.01% | 824 |
|
|
2019
Q2 | $520K | Sell |
10,765
-319
| -3% | -$15.3K | ﹤0.01% | 968 |
|
|
2019
Q1 | $560K | Sell |
11,084
-1,364
| -11% | -$80.5K | ﹤0.01% | 983 |
|
|
2018
Q4 | $738K | Sell |
12,448
-809
| -6% | -$52.2K | ﹤0.01% | 847 |
|
|
2018
Q3 | $873K | Buy |
13,257
+1,257
| +10% | +$73.3K | ﹤0.01% | 867 |
|
|
2018
Q2 | $606K | Buy |
12,000
+2,576
| +27% | +$134K | ﹤0.01% | 945 |
|
|
2018
Q1 | $496K | Buy |
9,424
+374
| +4% | +$18.6K | ﹤0.01% | 875 |
|
|
2017
Q4 | $421K | Buy |
9,050
+187
| +2% | +$7.87K | ﹤0.01% | 932 |
|
|
2017
Q3 | $359K | Buy |
8,863
+1,296
| +17% | +$46.9K | ﹤0.01% | 969 |
|
|
2017
Q2 | $257K | Buy |
7,567
+563
| +8% | +$17.4K | ﹤0.01% | 1068 |
|
|
2017
Q1 | $203K | Buy |
+7,004
| New | +$213K | ﹤0.01% | 1239 |
|
Other funds holding EBS
